Browse by Changes
Summary of Changes – 1 March 2025
Page last updated: 1 March 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber Bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- IVF Program
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Advance Notices
1 April 2025
Deletion – Brand
| 13828T | pms-SALBUTAMOL, DZ – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules |
General Pharmaceutical Benefits
Additions
Addition – Item
| 14726C | ACARBOSE, acarbose 50 mg tablet, 90 (Acarbose 50 mg tablets (Morningside, UK)) |
| 14735M | ACARBOSE, acarbose 50 mg tablet, 90 (Acarbose 50 mg tablets (Morningside, UK)) |
| 14722W | ACARBOSE, acarbose 100 mg tablet, 90 (Acarbose 100 mg tablets (Morningside, UK)) |
| 14734L | ACARBOSE, acarbose 100 mg tablet, 90 (Acarbose 100 mg tablets (Morningside, UK)) |
| 14711G | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 (Yasmin) |
| 14725B | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 (Yasmin) |
| 14709E | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 (Yaz) |
| 14710F | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 (Yaz) |
| 14712H | DULOXETINE, duloxetine 60 mg enteric capsule, 28 (APO-Duloxetine, DYTREX 60, Duloxecor, Duloxetine Sandoz 60, Duloxetine Sandoz, Tixol 60) |
| 14715L | ESTRADIOL, estradiol 100 microgram/24 hours patch, 24 (Estramon (Germany, Sandoz)) |
| 14719Q | ESTRADIOL, estradiol 0.06% (750 microgram/actuation) gel, 64 actuations (Estrogel) |
| 14741W | ESTRADIOL, estradiol 0.06% (750 microgram/actuation) gel, 64 actuations (Estrogel) |
| 14731H | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 (ESTALIS 250/50 (Canada)) |
| 14739R | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 (ESTALIS 250/50 (Canada)) |
| 14727D | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 (ESTALIS 140/50 (Canada)) |
| 14728E | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 (ESTALIS 140/50 (Canada)) |
| 14737P | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
| 14738Q | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
| 14717N | FLUOXETINE, fluoxetine 20 mg tablet, 28 (Zactin Tablet) |
| 14740T | GLICLAZIDE, gliclazide 30 mg modified release tablet, 100 (APO-Gliclazide MR, Gliclazide MR Viatris, Glyade MR, Pharmacor Gliclazide MR) |
| 14714K | OSILODROSTAT, osilodrostat 1 mg tablet, 60 (Isturisa) |
| 14723X | OSILODROSTAT, osilodrostat 1 mg tablet, 60 (Isturisa) |
| 14724Y | OSILODROSTAT, osilodrostat 5 mg tablet, 60 (Isturisa) |
| 14729F | OSILODROSTAT, osilodrostat 5 mg tablet, 60 (Isturisa) |
| 14730G | PROGESTERONE, progesterone 100 mg capsule, 30 (Prometrium) |
| 14733K | PROGESTERONE, progesterone 100 mg capsule, 30 (Prometrium) |
| 14720R | PROGESTERONE (&) ESTRADIOL, progesterone 100 mg capsule [30] (&) estradiol 0.06% (750 microgram/actuation) gel [64 actuations], 1 pack (Estrogel Pro) |
| 14721T | PROGESTERONE (&) ESTRADIOL, progesterone 100 mg capsule [30] (&) estradiol 0.06% (750 microgram/actuation) gel [64 actuations], 1 pack (Estrogel Pro) |
| 14713J | RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi) |
| 14732J | RISANKIZUMAB, risankizumab 150 mg/mL injection, 1 mL pen device (Skyrizi) |
| 14716M | URSODEOXYCHOLIC ACID, ursodeoxycholic acid 500 mg capsule, 100 (Ursodox GH) |
Addition – Brand
| 12360M | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12374G | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12419P | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12426B | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12447D | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12448E | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12449F | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 12450G | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 14587R | Hyrimoz, SZ – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 13929D | Dutasteride/Tamsulosin Sandoz 500/400, SZ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 |
| 5490Y | Dutasteride/Tamsulosin Sandoz 500/400, SZ – DUTASTERIDE + TAMSULOSIN, dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 |
| 8558K | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes |
| 8716R | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 20 mg/0.2 mL injection, 10 x 0.2 mL syringes |
| 8510X | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes |
| 8639Q | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 40 mg/0.4 mL injection, 10 x 0.4 mL syringes |
| 8262W | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes |
| 8640R | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 60 mg/0.6 mL injection, 10 x 0.6 mL syringes |
| 5434B | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes |
| 8263X | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 80 mg/0.8 mL injection, 10 x 0.8 mL syringes |
| 5435C | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes |
| 8264Y | Exarane Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 100 mg/mL injection, 10 x 1 mL syringes |
| 13688K | Exarane Forte Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 120 mg/0.8 mL injection, 10 x 0.8 mL syringes |
| 13710N | Exarane Forte Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 120 mg/0.8 mL injection, 10 x 0.8 mL syringes |
| 13717Y | Exarane Forte Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 150 mg/mL injection, 10 x 1 mL syringes |
| 13729N | Exarane Forte Safety-Lock, JO – ENOXAPARIN SODIUM, enoxaparin sodium 150 mg/mL injection, 10 x 1 mL syringes |
| 10019H | ERLOTINIB ARX, XT – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 10020J | ERLOTINIB ARX, XT – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 11260P | ERLOTINIB ARX, XT – ERLOTINIB, erlotinib 100 mg tablet, 30 |
| 10201X | Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 |
| 10204C | Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60 |
| 10207F | Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 |
| 10208G | Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 |
| 13480L | Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 |
| 13537L | Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 |
| 13569E | Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 |
| 13629H | Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg, SZ – EZETIMIBE (&) ROSUVASTATIN, ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60 |
| 13899M | Metformin Sandoz XR, SZ – METFORMIN, metformin hydrochloride 500 mg modified release tablet, 120 |
| 9435N | Metformin Sandoz XR, SZ – METFORMIN, metformin hydrochloride 500 mg modified release tablet, 120 |
| 13847T | Metformin Sandoz XR, SZ – METFORMIN, metformin hydrochloride 1 g modified release tablet, 60 |
| 3439B | Metformin Sandoz XR, SZ – METFORMIN, metformin hydrochloride 1 g modified release tablet, 60 |
Addition – Equivalence Indicator
| 14587R | Yuflyma, EW – ADALIMUMAB, adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device |
| 13688K | Exarane Forte, JU – ENOXAPARIN SODIUM, enoxaparin sodium 120 mg/0.8 mL injection, 10 x 0.8 mL syringes |
| 13717Y | Exarane Forte, JU – ENOXAPARIN SODIUM, enoxaparin sodium 150 mg/mL injection, 10 x 1 mL syringes |
| 14651D | Estramon 100 (Germany), DZ – ESTRADIOL, estradiol 100 microgram/24 hours patch, 24 |
| 14336M | Estalis continuous 50/250, SZ – ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 |
| 8428N | Estalis continuous 50/250, SZ – ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 |
| 13902Q | Estalis continuous 50/140, SZ – ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 |
| 8427M | Estalis continuous 50/140, SZ – ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 |
| 11180K | Ursofalk, FD – URSODEOXYCHOLIC ACID, ursodeoxycholic acid 500 mg tablet, 100 |
Addition – Note
| 13955L | ACARBOSE, acarbose 50 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
| 8188Y | ACARBOSE, acarbose 50 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
| 13869Y | ACARBOSE, acarbose 100 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
| 8189B | ACARBOSE, acarbose 100 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
| 14651D | ESTRADIOL, estradiol 100 microgram/24 hours patch, 24 (Estramon 100 (Germany)) |
| 14336M | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 (Estalis continuous 50/250) |
| 8428N | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch, 8 (Estalis continuous 50/250) |
| 13902Q | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 (Estalis continuous 50/140) |
| 8427M | ESTRADIOL + NORETHISTERONE ACETATE, estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch, 8 (Estalis continuous 50/140) |
| 11180K | URSODEOXYCHOLIC ACID, ursodeoxycholic acid 500 mg tablet, 100 (Ursofalk) |
Addition – Restriction
| 8188Y | ACARBOSE, acarbose 50 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
| 8189B | ACARBOSE, acarbose 100 mg tablet, 90 (Acarbose Viatris, GLYBOSAY) |
Deletions
Deletion – Item
| 14568R | AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 100 mL (CLAVULIN-125F (GlaxoSmithKline, Canada)) |
| 14569T | AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 100 mL (CLAVULIN-125F (GlaxoSmithKline, Canada)) |
| 14570W | AZITHROMYCIN, azithromycin 200 mg/5 mL powder for oral liquid, 15 mL (Azithromycin (Zydus, USA)) |
| 8341B | SUMATRIPTAN, sumatriptan 20 mg/actuation nasal spray, 2 x 1 actuation (Imigran) |
| 8526R | TENECTEPLASE, tenecteplase 40 mg injection [1 vial] (&) inert substance diluent [8 mL syringe], 1 pack (Metalyse) |
| 14241M | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol XE 0.50% (South Africa)) |
| 14301Q | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol XE 0.50% (South Africa)) |
Deletion – Brand
| 14425F | BetoQuin, NM – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 2825Q | BetoQuin, NM – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 5544T | BetoQuin, NM – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 8764G | Estradiol Transdermal System (Sandoz, USA), HX – ESTRADIOL, estradiol 75 microgram/24 hours patch, 8 |
| 13435D | Irbesartan GH, GQ – IRBESARTAN, irbesartan 75 mg tablet, 30 |
| 8246B | Irbesartan GH, GQ – IRBESARTAN, irbesartan 75 mg tablet, 30 |
| 13380F | Irbesartan GH, GQ – IRBESARTAN, irbesartan 150 mg tablet, 30 |
| 8247C | Irbesartan GH, GQ – IRBESARTAN, irbesartan 150 mg tablet, 30 |
| 13564X | Irbesartan GH, GQ – IRBESARTAN, irbesartan 300 mg tablet, 30 |
| 8248D | Irbesartan GH, GQ – IRBESARTAN, irbesartan 300 mg tablet, 30 |
| 8816B | Modafinil Mylan, AF – MODAFINIL, modafinil 100 mg tablet, 60 |
| 3382B | Olanzapine ODT generichealth 10, GQ – OLANZAPINE, olanzapine 10 mg orally disintegrating tablet, 28 |
| 2355Y | Cipla Pregabalin, LR – PREGABALIN, pregabalin 150 mg capsule, 56 |
| 8457D | Quetiapine APOTEX, GX – QUETIAPINE, quetiapine 100 mg tablet, 90 |
| 1968N | Accupril, PF – QUINAPRIL, quinapril 5 mg tablet, 30 |
| 13582W | Tryzan Tabs 1.25, AF – RAMIPRIL, ramipril 1.25 mg tablet, 30 |
| 1944H | Tryzan Tabs 1.25, AF – RAMIPRIL, ramipril 1.25 mg tablet, 30 |
| 13466R | Tryzan Tabs 2.5, AF – RAMIPRIL, ramipril 2.5 mg tablet, 30 |
| 1945J | Tryzan Tabs 2.5, AF – RAMIPRIL, ramipril 2.5 mg tablet, 30 |
| 13526X | Tryzan Tabs 5, AF – RAMIPRIL, ramipril 5 mg tablet, 30 |
| 1946K | Tryzan Tabs 5, AF – RAMIPRIL, ramipril 5 mg tablet, 30 |
| 1316G | Tryzan Tabs 10, AF – RAMIPRIL, ramipril 10 mg tablet, 30 |
| 13368N | Tryzan Tabs 10, AF – RAMIPRIL, ramipril 10 mg tablet, 30 |
Deletion – Equivalence Indicator
| 1892N | Curam, SZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 75 mL |
| 5009P | Curam, SZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 75 mL |
| 8201P | Zithromax, PF – AZITHROMYCIN, azithromycin 200 mg/5 mL powder for oral liquid, 15 mL |
| 14425F | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 2825Q | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 5544T | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
| 8764G | Estradot 75, SZ – ESTRADIOL, estradiol 75 microgram/24 hours patch, 8 |
| 1968N | ACQUIN, RF – QUINAPRIL, quinapril 5 mg tablet, 30 |
Deletion – Note
| 1892N | AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 75 mL (Curam) |
| 5009P | AMOXICILLIN + CLAVULANIC ACID, amoxicillin 125 mg/5 mL + clavulanic acid 31.25 mg/5 mL powder for oral liquid, 75 mL (Curam) |
| 8201P | AZITHROMYCIN, azithromycin 200 mg/5 mL powder for oral liquid, 15 mL (Zithromax) |
| 11123K | SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 (Entresto) |
| 13570F | SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 (Entresto) |
| 11131W | SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 (Entresto) |
| 13511D | SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 (Entresto) |
| 11122J | SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 (Entresto) |
| 13445P | SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 (Entresto) |
Alterations
Alteration – Item Description
| From | |
| 14126L | AMINO ACID FORMULA WITH VITAMINS AND MINERALS, WITHOUT PHENYLALANINE, TYROSINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals, without phenylalanine, tyrosine and supplemented with arachidonic acid and docosahexaenoic acid containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets (TYR explore5) |
| To | |
| 14126L | AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE, TYROSINE AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals without phenylalanine, tyrosine and supplemented with arachidonic acid and docosahexaenoic acid containing 5 g of protein equivalent powder for oral liquid, 30 x 12.5 g sachets (TYR explore5) |
Alteration – Brand Name
| From | |
| 11703Y | Zarontin, IX – ETHOSUXIMIDE, ethosuximide 250 mg capsule, 100 |
| To | |
| 11703Y | ZARONTIN, IX – ETHOSUXIMIDE, ethosuximide 250 mg capsule, 100 |
Alteration – Authorised Prescriber
| From | To | ||
| 11603Q | CLADRIBINE, cladribine 10 mg tablet, 1 (Mavenclad) | M | M,N |
| 11604R | CLADRIBINE, cladribine 10 mg tablet, 4 (Mavenclad) | M | M,N |
| 11611D | CLADRIBINE, cladribine 10 mg tablet, 6 (Mavenclad) | M | M,N |
| 2896K | DIMETHYL FUMARATE, dimethyl fumarate 120 mg enteric capsule, 14 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera) | M | M,N |
| 2943X | DIMETHYL FUMARATE, dimethyl fumarate 120 mg enteric capsule, 14 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera) | M | M,N |
| 2966D | DIMETHYL FUMARATE, dimethyl fumarate 240 mg enteric capsule, 56 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera, Trazent) | M | M,N |
| 13059H | DIROXIMEL FUMARATE, diroximel fumarate 231 mg enteric capsule, 120 (Vumerity) | M | M,N |
| 11484K | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) | M | M,N |
| 11985T | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) | M | M,N |
| 11818B | FINGOLIMOD, fingolimod 250 microgram capsule, 28 (Gilenya) | M | M,N |
| 5262Y | FINGOLIMOD, fingolimod 500 microgram capsule, 28 (AKM Fingolimod, Fingolimod SUN, Fingolimod Sandoz, Fingolimod-Teva, Fynod, Gilenya, Pharmacor Fingolimod) | M | M,N |
| 10416F | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL syringes (Copaxone, GLATIRAMER ACETATE-TEVA, Glatira) | M | M,N |
| 13110B | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL pen devices (Copaxone) | M | M,N |
| 14087K | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | M | M,N |
| 14101E | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | M | M,N |
| 14152W | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | M | M,N |
| 8101J | INTERFERON BETA-1B, interferon beta-1b 8 million units (250 microgram) injection [15 vials] (&) inert substance diluent [15 x 1.2 mL syringes], 1 pack (Betaferon) | M | M,N |
| 12641H | OFATUMUMAB, ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device (Kesimpta) | M | M,N |
| 12642J | OFATUMUMAB, ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device (Kesimpta) | M | M,N |
| 12271W | OZANIMOD, ozanimod 920 microgram capsule, 28 (Zeposia) | M | M,N |
| 12278F | OZANIMOD, ozanimod 230 microgram capsule [4] (&) ozanimod 460 microgram capsule [3], 7 (Zeposia) | M | M,N |
| 10212L | PEGINTERFERON BETA-1A, peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices (Plegridy) | M | M,N |
| 10220X | PEGINTERFERON BETA-1A, peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices (Plegridy) | M | M,N |
| 10218T | PEGINTERFERON BETA-1A, peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL pen device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL pen device], 1 pack (Plegridy) | M | M,N |
| 12160B | SIPONIMOD, siponimod 250 microgram tablet, 120 (Mayzent) | M | M,N |
| 12172P | SIPONIMOD, siponimod 250 microgram tablet, 12 (Mayzent) | M | M,N |
| 14607T | SIPONIMOD, siponimod 1 mg tablet, 28 (Mayzent) | M | M,N |
| 12158X | SIPONIMOD, siponimod 2 mg tablet, 28 (Mayzent) | M | M,N |
| 2898M | TERIFLUNOMIDE, teriflunomide 14 mg tablet, 28 (APO-TERIFLUNOMIDE, Pharmacor Teriflunomide, TERIFLAGIO, Teriflunomide Dr.Reddy's, Teriflunomide GH, Teriflunomide Sandoz, Terimide) | M | M,N |
Alteration – Note
| 10416F | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL syringes (Copaxone, GLATIRAMER ACETATE-TEVA, Glatira) |
| 13110B | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL pen devices (Copaxone) |
| 14087K | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 14101E | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 14152W | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 12642J | OFATUMUMAB, ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device (Kesimpta) |
| 14611B | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol-LA 0.5 % (Santen Oy, Finland)) |
| 14634F | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol-LA 0.5 % (Santen Oy, Finland)) |
| 1926J | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol XE) |
| 5550D | TIMOLOL, timolol 0.5% eye drops, 2.5 mL (Timoptol XE) |
Alteration – Restriction
| 11603Q | CLADRIBINE, cladribine 10 mg tablet, 1 (Mavenclad) |
| 11604R | CLADRIBINE, cladribine 10 mg tablet, 4 (Mavenclad) |
| 11611D | CLADRIBINE, cladribine 10 mg tablet, 6 (Mavenclad) |
| 2896K | DIMETHYL FUMARATE, dimethyl fumarate 120 mg enteric capsule, 14 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera) |
| 2943X | DIMETHYL FUMARATE, dimethyl fumarate 120 mg enteric capsule, 14 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera) |
| 2966D | DIMETHYL FUMARATE, dimethyl fumarate 240 mg enteric capsule, 56 (APO-DIMETHYL FUMARATE, Dimethyl Fumarate Sandoz, Pharmacor Dimethyl Fumarate, Tecfidera, Trazent) |
| 13059H | DIROXIMEL FUMARATE, diroximel fumarate 231 mg enteric capsule, 120 (Vumerity) |
| 11484K | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
| 11985T | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
| 11818B | FINGOLIMOD, fingolimod 250 microgram capsule, 28 (Gilenya) |
| 5262Y | FINGOLIMOD, fingolimod 500 microgram capsule, 28 (AKM Fingolimod, Fingolimod SUN, Fingolimod Sandoz, Fingolimod-Teva, Fynod, Gilenya, Pharmacor Fingolimod) |
| 10416F | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL syringes (Copaxone, GLATIRAMER ACETATE-TEVA, Glatira) |
| 13110B | GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL pen devices (Copaxone) |
| 14087K | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 14101E | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 14152W | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
| 8101J | INTERFERON BETA-1B, interferon beta-1b 8 million units (250 microgram) injection [15 vials] (&) inert substance diluent [15 x 1.2 mL syringes], 1 pack (Betaferon) |
| 12641H | OFATUMUMAB, ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device (Kesimpta) |
| 12642J | OFATUMUMAB, ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device (Kesimpta) |
| 12271W | OZANIMOD, ozanimod 920 microgram capsule, 28 (Zeposia) |
| 12278F | OZANIMOD, ozanimod 230 microgram capsule [4] (&) ozanimod 460 microgram capsule [3], 7 (Zeposia) |
| 10212L | PEGINTERFERON BETA-1A, peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices (Plegridy) |
| 10220X | PEGINTERFERON BETA-1A, peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices (Plegridy) |
| 10218T | PEGINTERFERON BETA-1A, peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL pen device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL pen device], 1 pack (Plegridy) |
| 12160B | SIPONIMOD, siponimod 250 microgram tablet, 120 (Mayzent) |
| 12172P | SIPONIMOD, siponimod 250 microgram tablet, 12 (Mayzent) |
| 14607T | SIPONIMOD, siponimod 1 mg tablet, 28 (Mayzent) |
| 12158X | SIPONIMOD, siponimod 2 mg tablet, 28 (Mayzent) |
| 2898M | TERIFLUNOMIDE, teriflunomide 14 mg tablet, 28 (APO-TERIFLUNOMIDE, Pharmacor Teriflunomide, TERIFLAGIO, Teriflunomide Dr.Reddy's, Teriflunomide GH, Teriflunomide Sandoz, Terimide) |
Alteration – Restriction Level
| From | To | ||
| 14101E | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | authority-required | streamlined |
| 14152W | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) | authority-required | streamlined |
Alteration – Manufacturer Code
| From | To | ||
| 12338J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12340L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12341M | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12342N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12345R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12347W | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12358K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12359L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12361N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12362P | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12363Q | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12364R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12373F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12375H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12376J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12377K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12378L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12379M | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12380N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12381P | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12382Q | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12383R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12389C | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12390D | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12391E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12397L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12398M | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12399N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12400P | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12405X | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12410E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12411F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12412G | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12413H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12414J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12421R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12422T | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12425Y | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12428D | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12429E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12430F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12432H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12433J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12442W | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12446C | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12451H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12453K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12454L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12455M | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13208E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13209F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13211H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13213K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13214L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13215M | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13216N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13217P | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13218Q | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13219R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13220T | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13221W | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13222X | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13223Y | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13224B | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13225C | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13226D | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13227E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13230H | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13691N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13703F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13704G | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13732R | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13763J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13764K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 14221L | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 14234E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 14242N | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 14272E | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 14586Q | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 14591Y | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 14628X | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 14629Y | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 5573H | Nicotinell Step 3 – NICOTINE, nicotine 7 mg/24 hours patch, 28 | ON | UI |
| 5572G | Nicotinell Step 2 – NICOTINE, nicotine 14 mg/24 hours patch, 28 | ON | UI |
| 3414Q | Nicotinell Step 1 – NICOTINE, nicotine 21 mg/24 hours patch, 28 | ON | UI |
| 5571F | Nicotinell Step 1 – NICOTINE, nicotine 21 mg/24 hours patch, 28 | ON | UI |
| 3054R | Lyclear – PERMETHRIN, permethrin 5% cream, 30 g | ON | UI |
Supply Only
Supply Only – Period Commencing
|
12262J |
INSULIN ISOPHANE HUMAN, insulin isophane human 100 units/mL injection, 5 x 3 mL pen devices (Protaphane InnoLet) |
Supply Only – Period Ending
|
10024N |
BUDESONIDE + FORMOTEROL, budesonide 50 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, 120 actuations (Symbicort Rapihaler 50/3) |
|
12100W |
BUDESONIDE + FORMOTEROL, budesonide 50 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, 120 actuations (Symbicort Rapihaler 50/3) |
|
9308X |
TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMER, triglycerides long chain with glucose polymer oral liquid, 18 x 250 mL cartons (ProZero) |
Advance Notices
1 April 2025
Deletion – Brand
| 8718W | Aripic Aripiprazole, LR – ARIPIPRAZOLE, aripiprazole 15 mg tablet, 30 |
| 8719X | Aripic Aripiprazole, LR – ARIPIPRAZOLE, aripiprazole 20 mg tablet, 30 |
| 8720Y | Aripic Aripiprazole, LR – ARIPIPRAZOLE, aripiprazole 30 mg tablet, 30 |
| 14452P | Celluvisc, VE – CARMELLOSE SODIUM, carmellose sodium 1% eye drops, 30 x 0.4 mL ampoules |
| 14522H | Cellufresh, VE – CARMELLOSE SODIUM, carmellose sodium 0.5% eye drops, 30 x 0.4 mL ampoules |
| 2324H | Celluvisc, VE – CARMELLOSE SODIUM, carmellose sodium 1% eye drops, 30 x 0.4 mL ampoules |
| 2338C | Cellufresh, VE – CARMELLOSE SODIUM, carmellose sodium 0.5% eye drops, 30 x 0.4 mL ampoules |
| 5505R | Celluvisc, VE – CARMELLOSE SODIUM, carmellose sodium 1% eye drops, 30 x 0.4 mL ampoules |
| 5506T | Cellufresh, VE – CARMELLOSE SODIUM, carmellose sodium 0.5% eye drops, 30 x 0.4 mL ampoules |
| 14675J | Clonazepam USP (Advagen Pharma, USA), LM – CLONAZEPAM, clonazepam 2 mg tablet, 100 |
| 13427Q | Clopidogrel Winthrop plus aspirin, WA – CLOPIDOGREL + ASPIRIN, clopidogrel 75 mg + aspirin 100 mg tablet, 30 |
| 9296G | Clopidogrel Winthrop plus aspirin, WA – CLOPIDOGREL + ASPIRIN, clopidogrel 75 mg + aspirin 100 mg tablet, 30 |
| 8566W | Recagon, OV – FOLLITROPIN BETA, follitropin beta 600 units/0.72 mL injection, 0.72 mL cartridge |
| 14478B | Minitran 10, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 10 mg/24 hours patch, 30 |
| 8028M | Minitran 10, IL – GLYCERYL TRINITRATE, glyceryl trinitrate 10 mg/24 hours patch, 30 |
| 1502C | Colifoam, GO – HYDROCORTISONE ACETATE, hydrocortisone acetate 10% enema, 21.1 g |
| 11417X | Ryzodeg Flextouch, NO – INSULIN DEGLUDEC + INSULIN ASPART, insulin degludec 70 units/mL + insulin aspart 30 units/mL injection, 5 x 3 mL pen devices |
| 1590Q | Orudis SR 200, SW – KETOPROFEN, ketoprofen 200 mg modified release capsule, 28 |
| 5136H | Orudis SR 200, SW – KETOPROFEN, ketoprofen 200 mg modified release capsule, 28 |
| 13867W | Lacoress, LR – LACOSAMIDE, lacosamide 100 mg tablet, 56 |
| 13951G | Lacoress, LR – LACOSAMIDE, lacosamide 200 mg tablet, 56 |
| 14053P | Lacoress, LR – LACOSAMIDE, lacosamide 150 mg tablet, 56 |
| 9333F | Lacoress, LR – LACOSAMIDE, lacosamide 50 mg tablet, 14 |
| 9334G | Lacoress, LR – LACOSAMIDE, lacosamide 100 mg tablet, 14 |
| 9335H | Lacoress, LR – LACOSAMIDE, lacosamide 100 mg tablet, 56 |
| 9336J | Lacoress, LR – LACOSAMIDE, lacosamide 150 mg tablet, 14 |
| 9337K | Lacoress, LR – LACOSAMIDE, lacosamide 150 mg tablet, 56 |
| 9338L | Lacoress, LR – LACOSAMIDE, lacosamide 200 mg tablet, 56 |
| 14038W | Provera, PF – MEDROXYPROGESTERONE, medroxyprogesterone acetate 500 mg tablet, 30 |
| 2728N | Provera, PF – MEDROXYPROGESTERONE, medroxyprogesterone acetate 500 mg tablet, 30 |
| 14000W | Mycophenolate APOTEX, GX – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 8650G | Mycophenolate APOTEX, GX – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 8186W | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 7.5 mg tablet, 28 |
| 5295Q | Aloxi, JZ – PALONOSETRON, palonosetron 250 microgram/5 mL injection, 5 mL vial |
| 1747Y | Panamax, SW – PARACETAMOL, paracetamol 24 mg/mL oral liquid, 100 mL |
| 3348F | Panamax, SW – PARACETAMOL, paracetamol 24 mg/mL oral liquid, 100 mL |
| 1896T | Feldene-D, PF – PIROXICAM, piroxicam 20 mg dispersible tablet, 25 |
| 5202T | Feldene-D, PF – PIROXICAM, piroxicam 20 mg dispersible tablet, 25 |
| 8456C | Quetiapine APOTEX, GX – QUETIAPINE, quetiapine 25 mg tablet, 60 |
| 8458E | Quetiapine APOTEX, GX – QUETIAPINE, quetiapine 200 mg tablet, 60 |
| 8580N | Quetiapine APOTEX, GX – QUETIAPINE, quetiapine 300 mg tablet, 60 |
| 13563W | Triasyn 2.5/2.5, SW – RAMIPRIL + FELODIPINE, ramipril 2.5 mg + felodipine 2.5 mg modified release tablet, 30 |
| 2626F | Triasyn 2.5/2.5, SW – RAMIPRIL + FELODIPINE, ramipril 2.5 mg + felodipine 2.5 mg modified release tablet, 30 |
| 13821K | pms-SALBUTAMOL, DZ – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules |
| 11276L | Tenofovir/Emtricitabine 300/200 APOTEX, TX – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
1 May 2025
Deletion – Brand
| 8565T | Recagon, OV – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
| 8871X | Recagon, OV – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
| 13412X | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
| 8679T | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
| 14421B | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
| 5524R | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
| 8676P | Optix, PP – POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL, polyethylene glycol-400 0.4% + propylene glycol 0.3% eye drops, 15 mL |
| 12160B | Mayzent, NV – SIPONIMOD, siponimod 250 microgram tablet, 120 |
1 June 2025
Deletion – Brand
| 12340L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12341M | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12342N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12345R | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12347W | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12358K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12362P | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12363Q | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12373F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12375H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12376J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12377K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12381P | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12383R | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12389C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12390D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12411F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12412G | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12414J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12425Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12428D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12429E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12432H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12433J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12446C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12454L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13211H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13214L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13215M | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13221W | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13223Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13224B | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13225C | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13226D | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13227E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13230H | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13691N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13703F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13764K | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 14221L | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 14234E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 14242N | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 14272E | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 14338P | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
| 14509P | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
| 1706T | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
| 1724R | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 |
| 2422L | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
| 5039F | Carbamazepine Sandoz, NM – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 |
| 13883Q | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
| 13910D | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
| 13911E | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
| 8658Q | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
| 8659R | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
| 8660T | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
| 5096F | Dicloxacillin Mylan 250, AL – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24 |
| 8121K | Dicloxacillin Mylan 250, AL – DICLOXACILLIN, dicloxacillin 250 mg capsule, 24 |
| 8187X | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 10 mg tablet, 28 |
| 1594X | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 10 |
| 1595Y | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 10 |
| 5471Y | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 4 |
| 5473C | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 10 |
| 8224W | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 4 |
| 8225X | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 4 |
| 13586C | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
| 2628H | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30 |
Palliative Care
Advance Notices
1 April 2025
Deletion – Brand
| 14674H | Clonazepam USP (Advagen Pharma, USA), LM – CLONAZEPAM, clonazepam 2 mg tablet, 100 |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Brand
| 14582L | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14583M | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14609X | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14610Y | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14624Q | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14631C | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
Addition – Equivalence Indicator
| 14582L | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14583M | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14609X | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14610Y | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14624Q | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14631C | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
Alterations
Alteration – Manufacturer Code
| From | To | ||
| 12335F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 12396K | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13210G | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 13229G | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
Advance Notices
1 April 2025
Deletion – Brand
| 11036W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 11042E | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 11055W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 11063G | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 11965R | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 28 |
| 11966T | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 28 |
| 11969Y | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 28 |
| 12004T | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 14 |
| 12011E | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12018M | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 14 |
| 12020P | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12037M | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12038N | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12050F | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12058P | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 14 |
| 12060R | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12068E | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12069F | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 14 |
| 12071H | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12980E | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12984J | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12986L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12993W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 13642B | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 13657T | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13658W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 13660Y | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 2796E | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 2798G | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 9642L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 9643M | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 9644N | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 9645P | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 6209T | Mycophenolate APOTEX, GX – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
1 June 2025
Deletion – Brand
| 12335F | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13229G | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12784W | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13033Y | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13038F | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13039G | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13040H | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 6100C | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 6138C | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 6352H | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
| 6353J | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
| 6354K | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Brand
| 14588T | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14592B | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14608W | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14616G | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14632D | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14633E | Lenalidomide Sandoz, SZ – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
Addition – Equivalence Indicator
| 14588T | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14592B | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14608W | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14616G | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14632D | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
| 14633E | Lenalide, JU – LENALIDOMIDE, lenalidomide 20 mg capsule, 21 |
Alterations
Alteration – Manufacturer Code
| From | To | ||
| 12431G | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
| 12444Y | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13212J | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices | OQ | RF |
| 13228F | Hadlima – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes | OQ | RF |
Advance Notices
1 April 2025
Deletion – Brand
| 11029L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 11041D | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 11062F | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 11064H | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 11964Q | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 28 |
| 11967W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 28 |
| 11968X | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 28 |
| 12012F | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 14 |
| 12019N | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 14 |
| 12026Y | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12034J | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12035K | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 14 |
| 12036L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12039P | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12057N | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12059Q | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12061T | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12062W | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 12070G | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 14 |
| 12979D | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 12985K | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 12988N | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 12991R | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13630J | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 13636Q | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 13641Y | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 13661B | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 2799H | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 2802L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 5783J | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 5 mg capsule, 21 |
| 5784K | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 10 mg capsule, 21 |
| 5785L | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 15 mg capsule, 21 |
| 5786M | Lenalidomide-Teva, TB – LENALIDOMIDE, lenalidomide 25 mg capsule, 21 |
| 9502D | Mycophenolate APOTEX, GX – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
1 June 2025
Deletion – Brand
| 12444Y | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 13212J | Adalicip, LR – ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices |
| 12771E | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13028Q | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13036D | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13042K | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 13044M | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 9597D | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 9598E | Azacitidine-Teva, TB – AZACITIDINE, azacitidine 100 mg injection, 1 vial |
| 5634M | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 25 mg capsule, 30 |
| 5635N | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 50 mg capsule, 30 |
| 5636P | Cyclosporin Sandoz, NM – CICLOSPORIN, ciclosporin 100 mg capsule, 30 |
Highly Specialised Drugs Program (Community Access)
Deletions
Deletion – Brand
| 10353X | Entecavir Mylan, AF – ENTECAVIR, entecavir 1 mg tablet, 30 |
Advance Notices
1 April 2025
Deletion – Brand
| 10290N | APO-Adefovir, TX – ADEFOVIR, adefovir dipivoxil 10 mg tablet, 30 |
| 10303G | Viramune XR, BY – NEVIRAPINE, nevirapine 400 mg modified release tablet, 30 |
| 10310P | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 11992E | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 10347N | Tenofovir/Emtricitabine 300/200 APOTEX, TX – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
IVF Program
Advance Notices
1 April 2025
Deletion – Brand
| 6336L | Recagon, OV – FOLLITROPIN BETA, follitropin beta 600 units/0.72 mL injection, 0.72 mL cartridge |
1 May 2025
Deletion – Brand
| 6335K | Recagon, OV – FOLLITROPIN BETA, follitropin beta 300 units/0.36 mL injection, 0.36 mL cartridge |
| 6464F | Recagon, OV – FOLLITROPIN BETA, follitropin beta 900 units/1.08 mL injection, 1.08 mL cartridge |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
| 14736N |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Alterations
Alteration – Note
| 11867N |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Alteration – Restriction
| 11116C |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
| 11867N |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Advance Notices
1 April 2025
Deletion – Brand
| 12508H | Bevaciptin, LR – BEVACIZUMAB, bevacizumab 400 mg/16 mL injection, 16 mL vial |
| 12508H | Bevaciptin, LR – BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 4 mL vial |
| 10383L | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10402L | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10589H | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10597R | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 7264H | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 7265J | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 7266K | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 7267L | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
| 14718P |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Alterations
Alteration – Note
| 11850Q |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Alteration – Restriction
| 11118E |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
| 11850Q |
BLINATUMOMAB, blinatumomab 38.5 microgram injection [1 vial] (&) inert substance solution [10 mL vial], 1 pack (Blincyto) |
Advance Notices
1 April 2025
Deletion – Brand
| 12479T | Bevaciptin, LR – BEVACIZUMAB, bevacizumab 400 mg/16 mL injection, 16 mL vial |
| 12479T | Bevaciptin, LR – BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 4 mL vial |
| 10391X | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10401K | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10581X | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 10588G | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 4632T | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 4639E | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 4650R | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
| 4703M | Kanjinti, JU – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial |
Related Pharmaceutical Benefits for Public Hospital use
Advance Notices
1 April 2025
Deletion – Brand
| 5853C | Aloxi, JZ – PALONOSETRON, palonosetron 250 microgram/5 mL injection, 5 mL vial |
1 June 2025
Deletion – Brand
| 5858H | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 4 |
| 5967C | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 4 mg tablet, 4 |
| 5968D | Ondansetron Mylan Tablets, AF – ONDANSETRON, ondansetron 8 mg tablet, 4 |
